NEILS SCOTT C (Interim CFO) sold 1.5% of their position (6.37K shares) of XTANT MEDICAL HOLDINGS, INC. on the open market
Open‑market sale worth $3.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/17/2022ACC: 0001235802-22-000100
Officer· Interim CFO
Since Jan 2022
+245.53K
Net shares
Net buyer
$3.1K
Total sold
2
Open market trades
0B · 2S
3
Total transactions
251.90K acquired · 6.37K disposed
Non-Derivative Transactions3
Common Stock, $0.000001 par value
Direct
Shares
+251.90K
Price / share
—
Trade value
—
% of position
150.7%
8/15/2022
167.11K→419K
Common Stock, $0.000001 par value
Direct
Shares
−5.10K
Price / share
$0.48
Trade value
$2.46K
% of position
1.2%
8/16/2022
419K→413.90K
Common Stock, $0.000001 par value
Direct
Shares
−1.27K
Price / share
$0.48
Trade value
$605.03
% of position
0.3%
8/17/2022
413.90K→412.63K
Total
Net shares
+245.53K
Net value
-$3.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.000001 par value Direct | 8/15/2022 | A · Award | +251.90K | — | — | 150.7% | 167.11K | 419K |
| Common Stock, $0.000001 par value Direct | 8/16/2022 | S · Sale | −5.10K | $0.48 | $2.46K | 1.2% | 419K | 413.90K |
| Common Stock, $0.000001 par value Direct | 8/17/2022 | S · Sale | −1.27K | $0.48 | $605.03 | 0.3% | 413.90K | 412.63K |
| Total | +245.53K | -$3.07K | ||||||
Derivative Transactions0
No derivative transactions reported